Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-3732
Vaccine 2004 Apr 16;2213-14:1810-9. doi: 10.1016/j.vaccine.2003.10.052.
Show Gene links Show Anatomy links

Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model.

Isaguliants MG, Zuber B, Boberg A, Sjöstrand D, Belikov SV, Rollman E, Zuber AK, Rechinsky VO, Rytting AS, Källander CF, Hinkula J, Kochetkov SN, Liu M, Wahren B.


???displayArticle.abstract???
Drug resistance is becoming a problem in the treatment of the human immunodeficiency virus type one (HIV-1). To obtain therapeutic DNA vaccines that would target multiple drug-resistance (DR) mutations, we cloned genes for DR HIV-1 reverse transcriptase (RT) and codon-optimized synthetic genes encoding clusters of human CTL epitopes located at the sites of DR-mutations (RT minigenes) and antibody and CTL-epitope tags. Expression of RT genes/minigenes in eukaryotic cells was confirmed by Western blotting and immunofluoresence staining with RT- or tag-specific antibodies. Immunization of mice with DR-RT gene induced no RT-specific antibodies. Immunization of HLA-A(*)0201-transgenic mice with RT minigenes induced RT-specific cellular responses detected by interferon-gamma secretion. This documents first steps in creating therapeutic vaccine against drug-resistant HIV strains.

???displayArticle.pubmedLink??? 15068865
???displayArticle.link??? Vaccine


Species referenced: Xenopus laevis
Genes referenced: mhc1-uaa
GO keywords: reverse transcription

???displayArticle.disOnts??? human immunodeficiency virus infectious disease